WuXi Biologics
↗Wuxi, China
WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. The company offers end-to-end solutions that enable partners to discover, develop, and manufacture biologics from concept to commercialization.
With a significant global footprint, WuXi Biologics operates manufacturing and research facilities across China, the United States, Ireland, Germany, and Singapore. The company is a key partner for pharmaceutical and biotechnology firms, supporting a vast portfolio of projects ranging from monoclonal antibodies to complex modalities like bispecific/multispecific antibodies and antibody-drug conjugates (ADCs).
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Biologics Contract Development and Manufacturing
SIZE & FINANCIALS
Employees:10001-50000
Revenue:$2B-$3B
Founded:2015
Ownership:public
Status:operating
STOCK
Exchange:SEHK
Ticker:2269
Market Cap:$17.8B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:mAb, Bispecific/Multispecific antibodies, ADC, Vaccines
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:WuXi AppTec
Subsidiaries:WuXi Vaccines, CMAB Biopharma Group
Key Partnerships:Vertex Pharmaceuticals, HanchorBio, Sinorda Biomedicine, BioNTech SE
COMPETITION
Position:Leader
Competitors:Lonza, Samsung Biologics, AGC Biologics, Catalent, Charles River Laboratories
LEADERSHIP
Key Executives:
Zhisheng (Chris) Chen - CEO
Jijie Gu - Chief Scientific Officer, EVP
Weichang Zhou - Chief Technology Officer, EVP
LINKS
Website:wuxibiologics.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of WuXi Biologics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with WuXi Biologics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.